Skip to main content

Month: September 2020

Reliance Steel & Aluminum Co. Announces Participation at the Morgan Stanley Virtual 8th Annual Laguna Conference

LOS ANGELES, Sept. 10, 2020 (GLOBE NEWSWIRE) — Reliance Steel & Aluminum Co. (NYSE: RS) announced today that James Hoffman, President and Chief Executive Officer, and Karla Lewis, Senior Executive Vice President and Chief Financial Officer, will participate in the Morgan Stanley Virtual 8th Annual Laguna Conference on Thursday, September 17, 2020. Reliance is scheduled to present virtually at 4:30 p.m. ET and will participate in virtual meetings with investors throughout the day.The presentation will be webcast live over the Internet, hosted on the Investors section of the Company’s website at investor.rsac.com. In addition to the live webcast, a replay will be available on the Company’s website for 90 days following the event.About Reliance Steel & Aluminum Co.Founded in 1939 and headquartered in Los Angeles, California,...

Continue reading

TransUnion to Present at Barclays 2020 Global Financial Services Conference

CHICAGO, Sept. 10, 2020 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) today announced that Chris Cartwright, President and CEO, will present at the Barclays 2020 Global Financial Services Conference on Tuesday, September 15, 2020. The presentation is scheduled to begin at 8:45 a.m. CST (9:45 a.m. EST). A live webcast of the presentation will be made available at the TransUnion Investor Relations website at http://www.transunion.com/tru. A replay will be available on the company’s website following the conclusion of the presentation.About TransUnion (NYSE: TRU)TransUnion is a global information and insights company that makes trust possible in the modern economy. We do this by providing a comprehensive picture of each person so they can be reliably and safely represented in the marketplace. As a result, businesses and consumers can transact...

Continue reading

Correction: Progress on asset backed debt financing and Placing to raise £1,683,000 before costs

Vast Resources plc / Ticker: VAST / Index: AIM / Sector: MiningThe following amendment has been made to the ‘Progress on asset backed debt financing and Placing to raise £1,683,000 before costs’ announcement released on 10 September 2020 at 07:00.Following the First Admission, the total issued share capital of the Company will be 12,471,402,534 and following the Second Admission this will be 13,360,069,200. All other details remain unchanged.10 September 2020Vast Resources plc(“Vast” or the “Company”)Progress on asset backed debt financing and Placing to raise £1,683,000 before costsVast Resources plc, the AIM-listed mining company, is pleased to update the market on progress on its asset backed debt financing process and to announce that it has raised in aggregate £1,683,000 before costs through a placing (the ‘Placing’) of 1,121,999,999...

Continue reading

Stantec to partner on Arctic Research Support contract

EDMONTON, Alberta and NEW YORK and ANCHORAGE, Alaska, Sept. 10, 2020 (GLOBE NEWSWIRE) — Global design firm Stantec will support Battelle on a 10-year, US$260-million Arctic Research Support and Logistics Services (ARSLS) contract from the US Government’s National Science Foundation (NSF). The team will provide infrastructure and logistics support to academic researchers conducting NSF-funded studies in Alaska, northern Canada, Greenland, and other Arctic areas. Specifically, Stantec will provide engineering, design, and planning services in support of new facilities as well as maintenance of existing facilities to enable research within some of the most remote locations, harsh weather conditions, and difficult terrain on Earth. The overall project scope will include the design of infrastructure and facilities in these remote locations....

Continue reading

Aqua Bio Technology (ABT) buys all rights to Moana Skincare and integrates backwards into the value chain.

ABT has been a distributor of products from Moana Skincare since 2017 and has had exclusive distribution rights in Europe, the Middle East and Africa. ABT now acquires all rights to Moana Skincare and integrates backwards in the value chain. The acquisition gives ABT control over the entire value chain from production to global distribution. ABT will maintain its local presence and knowledge by entering into an agreement with Moana Skincare New Zealand Limited for the distribution of the products in New Zealand and Australia. Through the acquisition, ABT further develops and strengthens its position as a supplier and distributor of certified organic and natural skin care products, and ABT expects to realize synergies through the utilization of its own and new market access.Moana Skincare currently consists of a portfolio of 19 skin care...

Continue reading

Aqua Bio Technology (ABT) kjøper alle rettigheter til Moana Skincare og integrerer bakover i verdikjeden.

ABT har siden 2017 vært distributør av produkter fra Moana Skincare og har hatt eksklusive distribusjonsrettigheter i Europa, Midt Østen og Afrika. ABT kjøper nå alle rettigheter til Moana Skincare og integrerer bakover i verdikjeden. Oppkjøpet gir ABT kontroll over hele verdikjeden fra produksjon til global distribusjon. ABT vil bevare lokal tilstedeværelse og kunnskap gjennom inngåelse av en avtale med Moana Skincare New Zealand Limited om distribusjon av produktene på New Zealand og Australia. Gjennom oppkjøpet videreutvikler og styrker ABT sin posisjon som leverandør og distributør av sertifiserte organiske og naturlige hudpleieprodukter, og ABT forventer å realisere synergier gjennom utnyttelse av egen og ny markedstilgang.Moana Skincare består i dag av en portefølje med 19 hudpleieprodukter hvor flertallet av produktene er basert...

Continue reading

InspireMD Announces Christina Brennan, M.D., MBA to Serve in Advisory Role for Pivotal Study of CGuard Carotid Stent System

TEL AVIV, Israel, Sept. 10, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced the addition of Dr. Christina Brennan as a strategic advisor to the company to assist with planning and execution of a pivotal study of the CGuard™ Carotid Stent System, CARENET-III, for prevention of stroke in patients in the United States. The company recently announced that it had received approval from the FDA for the company to proceed with this pivotal study.“We are pleased to have Dr. Brennan join the team as we advance our efforts of planning and execution of the CARENET-III pivotal trial. Dr. Brennan brings a wealth of experience to InspireMD with specific expertise in vascular and stent...

Continue reading

ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 22nd Annual Investment Conference

TORONTO and CAMBRIDGE, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in H.C. Wainwright & Co., 22nd Annual Investment Conference being held virtually September 14-16 2020.ProMIS’ Executive Chairman, Eugene Williams, will provide an update on the Company with special focus on the opportunities to detect, treat and ultimately prevent Alzheimer’s disease. Mr. Williams’ webcast presentation is scheduled for Tuesday, September 15, 2020 at 1:00 pm ET. The webcast will be available live and approximately 24 hours following the live presentation through the following link here...

Continue reading

Hermès International : Shares and voting rights as of 31 August 2020

HERMES INTERNATIONALSociété en Commandite par Actions with a capital of 53 840 400,12 € euros,Incorporated under the n° 572 076 396 RCS PARISWhose registered office is situated 24, rue du Faubourg Saint-Honoré 75008 PARIS FRANCEInformation relating to the total number of voting rights and of shares envisaged by the article L 233-8 of the French “Code de Commerce” and Article 223-16 of the General Regulations of French “Autorité des Marchés Financiers “(AMF)AttachmentShares and voting rights 31 August 2020

Continue reading

Hermès International : Actions et droits de vote au 31 août 2020

HERMES INTERNATIONALSociété en Commandite par Actions au capital de 53 840 400,12 € euros,immatriculée sous le n° 572 076 396 RCS PARISdont le siège social est fixé au 24, rue du Faubourg Saint-Honoré 75008 PARISInformations relatives au nombre total de droits de vote et d’actions prévues par l’article L 233-8 du Code de commerce et l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers (AMF)Pièce jointeActions et droits de vote du 31 août 2020

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.